Free
External
Discover how the principles of Replacement, Reduction, and Refinement are moving from policy to practical application in our upcoming webinar, "3Rs in Action: Bridging the Gap Between Policy and Practice."
This session brings together the UK's leading 3Rs authority and industry pioneers to provide a comprehensive look at the current landscape and future of ethical research.
Agenda
- Gain high-level insights from the National Centre for the 3Rs (NC3Rs) on recent strategic developments and what to expect on the horizon for 3Rs policy and funding in 2026.
- Explore real-world case studies from AstraZeneca on how they implement 3Rs strategies within a global R&D framework to drive scientific excellence and animal welfare.
- A deep dive into cutting-edge technologies that are providing robust alternatives to traditional animal models.
- A Q&A to discuss challenges in adoption and share best practices
Why Attend?
Whether you are a researcher, animal technician, or policy stakeholder, this webinar offers a unique opportunity to see how 3Rs theory is being transformed into everyday laboratory reality. Learn about the latest tools to support better science and improved animal welfare while staying ahead of regulatory shifts.
Anthony Holmes
Dr Anthony Holmes is Director of Science and Technology at the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs; www.nc3rs.org.uk). He has strategic oversight of the science and technology supported through NC3Rs; ensuring that the NC3Rs has a long-term and sustainable strategy for supporting the best science and technology and its use in practice to achieve 3Rs and wider scientific and economic benefits. Anthony is currently on secondment to the Government Office for Life Sciences where he is supporting the development and delivery of the UK national strategy on non-animal alternative methods. He is a member of the BIA Science and Innovation Community and the British Standards Institute Biotechnologies Committee. Anthony has a PhD from the University of Cambridge and worked as a post-doctoral researcher at the Babraham Institute, Cambridge exploring the molecular mechanisms behind calcium signalling pathways and their role in human health and disease.
Dr Emma Lawrence
What does your role at BIA involve?
Emma leads BIA's genomics, digital, data and artificial intelligence (AI) policy areas. She engages with members who work in these fields to understand their policy needs. Emma provides the secretariat for BIA's Genomics Advisory Committee (GAC) and looks after the TechBio community as part of this. Emma also leads BIA's influence agenda for these areas, engaging with civil servants and other senior stakeholders.
Previous experience
Prior to joining the BIA, Emma worked at the cross-party think tank Policy Connect on a Cell and Gene Therapy Parliamentary engagement programme. She has previously worked in the biomedical research sector understanding the barriers to accessing human samples and data for research. This included leading engagement at the UKCRC Tissue Directory and Coordination Centre (UCL) and the Immunotherapy Trial Simulation Project (Imperial College London). Emma has a PhD in Immunology from the University of Manchester.
If you could invite any scientist or entrepreneur to dinner, who would it be and why?
Ada Lovelace, the godmother of computer programming because she was the first to recognise that a machine would have uses beyond calculations. We’d chat about maths and 19th-century gossip over cocktails.
BIA Annual Supporters
